SCHEMBL15519124

SCHEMBL15519124

CCOC(=O)c1cc([Si](C)(C)C)nn1-c1ccc(O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
POLB P06746 1/20 0.52
LMNA P02545 3/20 0.48
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA7 P43166 3/20 0.45
CA9 Q16790 3/20 0.45
CA14 Q9ULX7 3/20 0.45
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
KMT2A Q03164 2/20 0.44
USP2 O75604 1/20 0.44
HTT P42858 1/20 0.44
ADORA1 P30542 1/20 0.44
PDE4D Q08499 3/20 0.42
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
NPC1 O15118 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15517521 0.88 ALDH1A1 (0.51) ALDH1A1POLBLMNACA1CA2
SCHEMBL16931589 0.85 ALDH1A1 (0.48) ALDH1A1POLBLMNAKMT2AUSP2
SCHEMBL1877271 0.85 SMN1; SMN2 (0.52) ALDH1A1POLBLMNACA12CA1
SCHEMBL16990177 0.82 ALDH1A1 (0.46) ALDH1A1POLBLMNAKMT2AUSP2
SCHEMBL15516831 0.82 POLB (0.45) ALDH1A1POLBLMNAKMT2AUSP2
SCHEMBL16990181 0.81 ALDH1A1 (0.60) ALDH1A1POLBLMNACA9KMT2A
SCHEMBL15519989 0.79 ALDH1A1 (0.45) ALDH1A1POLBLMNAKMT2AHTT
SCHEMBL15517374 0.79 ALDH1A1 (0.58) ALDH1A1POLBLMNACA9KMT2A
SCHEMBL16990180 0.79 ALDH1A1 (0.57) ALDH1A1POLBLMNACA9KMT2A
SCHEMBL15517367 0.78 ALDH1A1 (0.44) ALDH1A1POLBLMNAKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9783556-B2 Kinase inhibitors RESPIVERT LIMITED (GB) 2017-10-10 US disclosed
EP-2890701-B1 KINASE INHIBITORS RESPIVERT LTD (GB) 2017-03-29 EP disclosed
US-20150225427-A1 KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2015-08-13 US disclosed
EP-2890701-A1 KINASE INHIBITORS Respivert Limited (GB) 2015-07-08 EP disclosed
WO-2014033449-A1 KINASE INHIBITORS RESPIVERT LIMITED (GB) 2014-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150225427-A1 KINASE INHIBITORS SYK, LYN, BTK ALDH1A1 2547/4885POLB 3759/4885LMNA 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.